Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways.

Benlahrech A, Donaghy H, Rozis G, Goodier M, Klavinskis L, Gotch F, Patterson S.

Sensors (Basel). 2009;9(1):386-403. doi: 10.3390/s90100386. Epub 2009 Jan 9.

2.

The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, Trinchieri G.

J Immunol. 2005 Jan 15;174(2):727-34.

3.

MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells.

Drénou B, Amiot L, Setterblad N, Taque S, Guilloux V, Charron D, Fauchet R, Mooney N.

J Leukoc Biol. 2005 Apr;77(4):560-7. Epub 2005 Jan 12.

PMID:
15647325
4.

Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells.

Shi CC, Tjwa ET, Biesta PJ, Boonstra A, Xie Q, Janssen HL, Woltman AM.

J Viral Hepat. 2012 Feb;19(2):e26-33. doi: 10.1111/j.1365-2893.2011.01496.x. Epub 2011 Aug 31.

PMID:
22239523
5.

Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.

Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, Asaad R, Heinzel FP, Tary-Lehmann M, Lederman MM, Anthony DD.

J Virol. 2009 Nov;83(21):11175-87. doi: 10.1128/JVI.00753-09. Epub 2009 Aug 19.

7.

IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Zhang S, Saha B, Kodys K, Szabo G.

J Hepatol. 2013 Sep;59(3):442-9. doi: 10.1016/j.jhep.2013.04.022. Epub 2013 May 7.

8.

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

Krug A, Rothenfusser S, Hornung V, Jahrsdörfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G.

Eur J Immunol. 2001 Jul;31(7):2154-63.

9.

Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.

Pahl JH, Verhoeven DH, Kwappenberg KM, Vellinga J, Lankester AC, van Tol MJ, Schilham MW.

Mol Immunol. 2012 May;51(1):91-100. doi: 10.1016/j.molimm.2012.02.119. Epub 2012 Mar 16.

PMID:
22424784
11.

Dendritic cells from human mesenteric lymph nodes in inflammatory and non-inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells.

Hostmann A, Kapp K, Beutner M, Ritz JP, Loddenkemper C, Ignatius R, Duchmann R, Daum S, Gröne J, Hotz H, Buhr HJ, Zeitz M, Ullrich R.

Immunology. 2013 May;139(1):100-8. doi: 10.1111/imm.12060.

13.

A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection.

Barr DP, Belz GT, Reading PC, Wojtasiak M, Whitney PG, Heath WR, Carbone FR, Brooks AG.

Eur J Immunol. 2007 May;37(5):1334-42.

14.

Reciprocal activating interaction between natural killer cells and dendritic cells.

Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G.

J Exp Med. 2002 Feb 4;195(3):327-33.

15.
16.

Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G.

J Immunol. 2003 May 1;170(9):4465-74.

17.

Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.

Dons'koi BV, Chernyshov VP, Osypchuk DV.

J Immunol Methods. 2011 Sep 30;372(1-2):187-95. doi: 10.1016/j.jim.2011.07.016. Epub 2011 Aug 2.

PMID:
21839083
18.

Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.

Wong JL, Mailliard RB, Moschos SJ, Edington H, Lotze MT, Kirkwood JM, Kalinski P.

J Immunother. 2011 Apr;34(3):270-8. doi: 10.1097/CJI.0b013e31820b370b.

19.
20.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976

Supplemental Content

Support Center